Delivery included to the United States

Programmed Cell Death in Cancer Progression and Therapy

Programmed Cell Death in Cancer Progression and Therapy - Advances in Experimental Medicine and Biology

Softcover reprint of hardcover 1st ed. 2008

Paperback (25 Nov 2010)

  • $225.70
Add to basket

Includes delivery to the United States

10+ copies available online - Usually dispatched within 7 days

Publisher's Synopsis

Programmed cell death (PCD) plays pivotal roles in tumor progression, cancer therapeutics and resistance of tumor cells to therapy. With the discovery of key mechanisms that are involved in mediating PCD and in promoting resistance to therapy, design of therapeutic approaches for promoting tumor-selective cell death has risen dramatically. With this book, we give a comprehensive overview of the mechanisms that are involved in mediating and regulating PCD in cancer. We also provide a detailed indication of the utility of PCD in cancer therapy. This book will be a valuable resource for researchers investigating the role of PCD in cancer and other diseases, researchers investigating the molecular mechanism of chemotherapeutic agents and drug-resistance in cancer and for physicians using chemotherapeutic agents. Additionally, this book will be a important educational source for PhD students specializing in cell biology, immunology and MD students interested in Oncology and Cancer Therapeutics.

Book information

ISBN: 9789048176687
Publisher: Springer Netherlands
Imprint: Springer
Pub date:
Edition: Softcover reprint of hardcover 1st ed. 2008
Language: English
Number of pages: 356
Weight: 612g
Height: 240mm
Width: 165mm
Spine width: 20mm